Apple Respiratory Study
Stopped early
Conditions studied: Acute Respiratory Infection, Coronavirus Infection, Influenza
In brief
The Apple Respiratory Study, a collaboration between researchers at Apple Inc. (the "Study Sponsor" or "Sponsor") and the Seattle Flu Study team at the University of Washington (UW) (the "UW Study Team"), is a prospective, longitudinal cohort, low risk Study to collect certain data from Apple Watch and iPhone to determine whether such data can detect physiologic and non-physiologic changes in individuals associated with respiratory illnesses due to influenza, SARS-CoV-2 and other respiratory pathogens (the "Study").
Key facts
- Study ID
- NCT04912180
- Run by
- Apple Inc.
- People needed
- 108
- Starts
- 2021-04-06
- Expected to finish
- 2021-06-09
- Last updated by the study team
- 2021-07-14
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- To participate in this Study, individuals must:
- Have access to an iPhone 6s or later with compatible iOS as defined by the Apple App Store.
- Have regular and reliable internet access
- Be willing to comply with all Study procedures, including regular use of the Apple Watch (daytime and nighttime), complete the REDCap and Apple Research app surveys, share data from required Apple Watch and iPhone sensors, and perform self-collected nasal swabs
- Be able to read and comprehend English
- Be able to provide informed consent without the use of a legally authorized representative
- Have a permanent mailing address in the greater Seattle area where Study materials can be mailed
- Be at least 22 years old at the time of consent
You may not qualify if…
- To participate in this Study, individuals must not:
- Have previously tested positive for SARS-CoV-2 via PCR or antibody test
- Currently be enrolled in University of Washington Husky Coronavirus Testing, Household Observation Study, or any other Seattle Flu Study sub-Study
- Have received any vaccine for COVID-19 or have an upcoming appointment for at least one dose of any COVID-19 vaccine prior to Study consent
- Individuals also may be excluded from the Study once target participant counts have been achieved for certain demographics, comorbidity groups, and/or residence based on zip code
Where it is running
- University of Washington — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.